바이오인

 

The 2013 "EU Industrial R&D Investment Scoreboard" (the Scoreboard) contains economic and financial data for the world's top 2000 companies ranked by their investments in research and development (R&D). The sample contains 527 companies based in the EU and 1473 companies based elsewhere. The Scoreboard data are drawn from the latest available companies' accounts, i.e. usually the fiscal year 2012 or 2012/131.

 

 

Trends observed show a significant variation in R&D investment and economic results across industries and sectors. This reflects persistent market uncertainties, in particular regarding the uneven potential for growth of international markets and the macroeconomic background. More salient facts observed from the analysis of 2012 and historic company data since 2003 include:

? A general remarkable resilience of R&D investment growth from top world R&D investors, in a period of economic uncertainty.

? The 527 EU companies featuring among the top world 2000 R&D investors in 2012 increased their investment in R&D by 6.3%, above world average (6.2%) but below the growth of their US counterparts (8.2%). EU overall positive numbers are largely driven by the R&D growth rates of German companies, particularly in the Automobile sector.

? Volkswagen with €9.5bn invested in R&D leads the world R&D ranking. In second place is Samsung Electronics (€8.3bn) from South Korea.

? In addition to a good performance in the Automobiles & Parts sector, EU-based companies outperformed the R&D growth of their US counterparts in Industrial Engineering (12.3% vs. 9.4%) and Aerospace & Defence (9.5% vs. -1.3%).

? The US continues to increase its specialisation in the high R&D-intensive sectors of ICT and health. Among the top 100 R&D investors, five ICT companies based in the US are among the best performers (increasing R&D and sales by more than 200% from 2004 to 2013). In the biotech sector, nine of the top ten companies are based in this country.

? An analysis of foreign direct investments (FDI) by the companies in the world R&D ranking shows that the EU plays, together with the US, a major role in the international investment scenario, both as a source and destination of cross-border R&D activities. From 2003 to 2012, the EU attracted 22% of FDI projects on R&D from the set of non-EU companies.

 

Top world R&D investors continued to increase their investment efforts in research and development significantly (6.2%) in 2012. This happened in a global context marked by a general slow-down of net sales growth (4.2% vs. 9.9% in 2011) and a decline in operating profits (-10.1%).

During the three years following the financial crisis in 2008-2009, Scoreboard companies increased their R&D investments by an average 6.2% per year (2010-2012). This resilience of companies' R&D investments during a period of economic uncertainty reflects the strategic importance that companies attach to such investment. Figure S1 below shows the longerterm R&D trends for a subset of Scoreboard companies with available data for the past nine years.

 

 

.......(계속)